Andreas Hofmann1,2, Thore Thiesler3, Bertran Gerrits4, Silvia Behnke3, Nadine Sobotzki1,5, Ulrich Omasits1, Damaris Bausch-Fluck1,5, Thomas Bock1, Ruedi Aebersold1,6, Holger Moch3, Marianne Tinguely3, Bernd Wollscheid1,5. 1. Department of Biology, Institute of Molecular Systems Biology, Swiss Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland. 2. Ph.D. Program in Molecular Life Sciences, University of Zurich (UZH)/ETH Zurich, Zurich, Switzerland. 3. Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland. 4. Functional Genomics Center Zurich, UZH/ETH Zurich, Zurich, Switzerland. 5. Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland. 6. Faculty of Science, UZH, Zurich, Switzerland.
Abstract
PURPOSE: Classical Hodgkin lymphoma (cHL) is characterized by a low percentage of tumor cells in a background of diverse, reactive immune cells. cHL cells commonly derive from preapoptotic germinal-center B cells and are characterized by the loss of B-cell markers and the varying expression of other hematopoietic lineage markers. This phenotypic variability and the scarcity of currently available cHL-specific cell surface markers can prevent clear distinction of cHL from related lymphomas. EXPERIMENTAL DESIGN: We applied the cell surface capture technology to directly measure the pool of cell surface exposed proteins in four cHL and four non-Hodgkin lymphoma (NHL) cell lines. RESULTS: More than 1000 membrane proteins, including 178 cluster of differentiation annotated proteins, were identified and allowed the generation of lymphoma surfaceome maps. The functional properties of identified cell surface proteins enable, but also limit the information exchange of lymphoma cells with their microenvironment. CONCLUSION AND CLINICAL RELEVANCE: Selected candidate proteins with potential diagnostic value were evaluated on a tissue microarray (TMA). Primary lymphoma tissues of 126 different B cell-derived lymphoma cases were included in the TMA analysis. The TMA analysis indicated gamma-glutamyltranspeptidase 1 as a potential additional marker that can be included in a panel of markers for differential diagnosis of cHL versus NHL.
PURPOSE:Classical Hodgkin lymphoma (cHL) is characterized by a low percentage of tumor cells in a background of diverse, reactive immune cells. cHL cells commonly derive from preapoptotic germinal-center B cells and are characterized by the loss of B-cell markers and the varying expression of other hematopoietic lineage markers. This phenotypic variability and the scarcity of currently available cHL-specific cell surface markers can prevent clear distinction of cHL from related lymphomas. EXPERIMENTAL DESIGN: We applied the cell surface capture technology to directly measure the pool of cell surface exposed proteins in four cHL and four non-Hodgkin lymphoma (NHL) cell lines. RESULTS: More than 1000 membrane proteins, including 178 cluster of differentiation annotated proteins, were identified and allowed the generation of lymphoma surfaceome maps. The functional properties of identified cell surface proteins enable, but also limit the information exchange of lymphoma cells with their microenvironment. CONCLUSION AND CLINICAL RELEVANCE: Selected candidate proteins with potential diagnostic value were evaluated on a tissue microarray (TMA). Primary lymphoma tissues of 126 different B cell-derived lymphoma cases were included in the TMA analysis. The TMA analysis indicated gamma-glutamyltranspeptidase 1 as a potential additional marker that can be included in a panel of markers for differential diagnosis of cHL versus NHL.
Authors: Nicole A Haverland; Matthew Waas; Ioanna Ntai; Theodore Keppel; Rebekah L Gundry; Neil L Kelleher Journal: Proteomics Date: 2017-10 Impact factor: 3.984
Authors: Tina Glisovic-Aplenc; Saar Gill; Lynn A Spruce; Ian R Smith; Hossein Fazelinia; Olga Shestova; Hua Ding; Sarah K Tasian; Richard Aplenc; Steven H Seeholzer Journal: Proteomics Date: 2017-03-06 Impact factor: 3.984
Authors: André L Fonseca; Vandeclécio L da Silva; Marbella M da Fonsêca; Isabella T J Meira; Thayná E da Silva; José E Kroll; André M Ribeiro-Dos-Santos; Cléber R Freitas; Raimundo Furtado; Jorge E de Souza; Beatriz Stransky; Sandro J de Souza Journal: Int J Genomics Date: 2016-11-14 Impact factor: 2.326
Authors: Tamás Langó; Gergely Róna; Éva Hunyadi-Gulyás; Lilla Turiák; Julia Varga; László Dobson; György Várady; László Drahos; Beáta G Vértessy; Katalin F Medzihradszky; Gergely Szakács; Gábor E Tusnády Journal: Sci Rep Date: 2017-02-13 Impact factor: 4.379
Authors: Siddhartha S Saha; Nyssa B Samanas; Irina Miralda; Nicholas J Shubin; Kerri Niino; Gauri Bhise; Manasa Acharya; Albert J Seo; Nathan Camp; Gail H Deutsch; Richard G James; Adrian M Piliponsky Journal: J Allergy Clin Immunol Date: 2021-07-27 Impact factor: 10.793
Authors: Robyn A A Oldham; Mary L Faber; Theodore R Keppel; Amanda R Buchberger; Matthew Waas; Parameswaran Hari; Rebekah L Gundry; Jeffrey A Medin Journal: J Immunother Cancer Date: 2020-08 Impact factor: 13.751